West Pharmaceutical Services (WST) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

West Pharmaceutical Services Revenue Highlights

Latest Revenue (Y)

$2.89B

Latest Revenue (Q)

$746.90M

Main Segment (Y)

Contract Manufactured Products

Main Geography (Y)

UNITED STATES

West Pharmaceutical Services Revenue by Period

West Pharmaceutical Services Revenue by Year

Date	Revenue	Change
2024-12-31	$2.89B	-1.92%
2023-12-31	$2.95B	2.18%
2022-12-31	$2.89B	1.95%
2021-12-31	$2.83B	31.89%
2020-12-31	$2.15B	16.69%
2019-12-31	$1.84B	7.13%
2018-12-31	$1.72B	7.40%
2017-12-31	$1.60B	5.96%
2016-12-31	$1.51B	7.81%
2015-12-31	$1.40B	-1.52%
2014-12-31	$1.42B	3.87%
2013-12-31	$1.37B	8.05%
2012-12-31	$1.27B	6.21%
2011-12-31	$1.19B	7.93%
2010-12-31	$1.10B	4.64%
2009-12-31	$1.06B	0.44%
2008-12-31	$1.05B	3.04%
2007-12-31	$1.02B	11.69%
2006-12-31	$913.30M	30.53%
2005-12-31	$699.70M	29.19%
2004-12-31	$541.60M	10.37%
2003-12-31	$490.70M	16.92%
2002-12-31	$419.70M	5.74%
2001-12-31	$396.90M	-7.72%
2000-12-31	$430.10M	-8.31%
1999-12-31	$469.10M	4.31%
1998-12-31	$449.70M	-0.62%
1997-12-31	$452.50M	-1.37%
1996-12-31	$458.80M	11.12%
1995-12-31	$412.90M	13.09%
1994-12-31	$365.10M	4.70%
1993-12-31	$348.70M	-

West Pharmaceutical Services generated $2.89B in revenue during NA 2024, up -1.92% compared to the previous quarter, and up 157.25% compared to the same period a year ago.

West Pharmaceutical Services Revenue by Quarter

Date	Revenue	Change
2024-09-30	$746.90M	6.40%
2024-06-30	$702.00M	0.95%
2024-03-31	$695.40M	-5.00%
2023-12-31	$732.00M	-2.06%
2023-09-30	$747.40M	-0.85%
2023-06-30	$753.80M	5.19%
2023-03-31	$716.60M	1.11%
2022-12-31	$708.70M	3.17%
2022-09-30	$686.90M	-10.94%
2022-06-30	$771.30M	7.13%
2022-03-31	$720.00M	-1.48%
2021-12-31	$730.80M	3.44%
2021-09-30	$706.50M	-2.36%
2021-06-30	$723.60M	7.89%
2021-03-31	$670.70M	15.60%
2020-12-31	$580.20M	5.88%
2020-09-30	$548.00M	3.95%
2020-06-30	$527.20M	7.26%
2020-03-31	$491.50M	4.44%
2019-12-31	$470.60M	3.18%
2019-09-30	$456.10M	-2.90%
2019-06-30	$469.70M	5.91%
2019-03-31	$443.50M	4.97%
2018-12-31	$422.50M	-2.13%
2018-09-30	$431.70M	-3.53%
2018-06-30	$447.50M	7.65%
2018-03-31	$415.70M	0.02%
2017-12-31	$415.60M	4.37%
2017-09-30	$398.20M	0.15%
2017-06-30	$397.60M	2.55%
2017-03-31	$387.70M	1.41%
2016-12-31	$382.30M	1.49%
2016-09-30	$376.70M	-2.91%
2016-06-30	$388.00M	7.15%
2016-03-31	$362.10M	0.67%
2015-12-31	$359.70M	4.41%
2015-09-30	$344.50M	-4.23%
2015-06-30	$359.70M	7.09%
2015-03-31	$335.90M	-3.97%
2014-12-31	$349.80M	-1.71%
2014-09-30	$355.90M	-3.52%
2014-06-30	$368.90M	6.37%
2014-03-31	$346.80M	1.20%
2013-12-31	$342.70M	0.26%
2013-09-30	$341.80M	-0.78%
2013-06-30	$344.50M	1.50%
2013-03-31	$339.40M	5.57%
2012-12-31	$321.50M	5.83%
2012-09-30	$303.80M	-6.47%
2012-06-30	$324.80M	2.69%
2012-03-31	$316.30M	7.08%
2011-12-31	$295.40M	0.61%
2011-09-30	$293.60M	-4.64%
2011-06-30	$307.90M	4.23%
2011-03-31	$295.40M	6.72%
2010-12-31	$276.80M	1.99%
2010-09-30	$271.40M	-3.69%
2010-06-30	$281.80M	2.58%
2010-03-31	$274.70M	-6.37%
2009-12-31	$293.40M	13.33%
2009-09-30	$258.90M	-0.80%
2009-06-30	$261.00M	7.67%
2009-03-31	$242.40M	-0.98%
2008-12-31	$244.80M	-4.45%
2008-09-30	$256.20M	-8.27%
2008-06-30	$279.30M	3.18%
2008-03-31	$270.70M	5.70%
2007-12-31	$256.10M	-

West Pharmaceutical Services generated $746.90M in revenue during Q3 2024, up 6.40% compared to the previous quarter, and up 99.08% compared to the same period a year ago.

West Pharmaceutical Services Revenue Breakdown

West Pharmaceutical Services Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Contract Manufactured Products	$558.70M	$552.50M	$480.40M	$514.70M	$498.60M
Proprietary Products	-	$2.40B	$2.41B	$2.32B	$1.65B

West Pharmaceutical Services's latest annual revenue breakdown by segment (product or service), as of Dec 24: Contract Manufactured Products (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19
Contract Manufactured Products	$134.90M	$145.50M	$142.40M	$135.90M	$419.00M	$133.50M	$118.70M	$127.10M	-	-	-	-	-	-	-	-	-	-	-	-
Proprietary Products	-	-	-	-	$1.81B	$583.10M	$601.30M	$543.70M	-	-	-	-	-	-	-	-	-	-	-	-
Packaging Systems	-	-	-	-	-	$602.50M	$567.00M	$653.70M	$577.00M	$587.30M	$421.50M	$399.50M	$373.50M	$345.20M	$360.30M	$340.40M	-	-	-	-
Delivery Systems	-	-	-	-	-	$144.90M	$135.80M	$120.00M	$117.80M	$129.70M	$136.40M	$126.60M	$127.80M	$118.10M	$111.10M	$109.40M	$103.10M	-	-	-
Intersegment Eliminations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-100.00K	$-200.00K	-	-

West Pharmaceutical Services's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Contract Manufactured Products (100.00%).

West Pharmaceutical Services Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
UNITED STATES	$1.23B	$1.24B	$1.29B	$1.20B	$975.60M
IRELAND	$323.20M	$285.70M	$240.30M	$247.60M	$226.00M
GERMANY	$372.50M	$406.10M	$398.70M	$474.30M	$282.10M
FRANCE	$242.20M	$282.90M	$237.90M	$213.00M	$172.70M
Other Europe Countries	-	$388.10M	$359.20M	$341.30M	$236.80M
Other Countries	-	$348.50M	$364.30M	$357.40M	$253.70M

West Pharmaceutical Services's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (56.75%), GERMANY (17.18%), IRELAND (14.90%), and FRANCE (11.17%).

West Pharmaceutical Services Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BDX	Becton, Dickinson and	$20.18B	$5.17B
ALC	Alcon	$10.09B	$2.46B
RMD	ResMed	$4.69B	$1.22B
BAX	Baxter	$4.51B	$3.81B
HOLX	Hologic	$4.03B	$1.02B
COO	Cooper Companies	$3.90B	$964.70M
TFX	Teleflex	$3.05B	$764.38M
WST	West Pharmaceutical Services	$2.89B	$746.90M
ICUI	ICU Medical	$2.38B	$589.13M
HAE	Haemonetics	$1.31B	$348.54M
MMSI	Merit Medical Systems	$1.30B	$339.85M
EMBC	Embecta	$1.12B	$261.90M
RGEN	Repligen	$634.44M	$141.19M

WST Revenue FAQ

What is West Pharmaceutical Services’s yearly revenue?

West Pharmaceutical Services's yearly revenue for 2024 was $2.89B, representing a decrease of -1.92% compared to 2023. The company's yearly revenue for 2023 was $2.95B, representing an increase of 2.18% compared to 2022. WST's yearly revenue for 2022 was $2.89B, representing an increase of 1.95% compared to 2021.

What is West Pharmaceutical Services’s quarterly revenue?

West Pharmaceutical Services's quarterly revenue for Q3 2024 was $746.9M, a 6.40% increase from the previous quarter (Q2 2024), and a -0.07% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $702M, a 0.95% increase from the previous quarter (Q1 2024), and a -6.87% decrease year-over-year (Q2 2023). WST's quarterly revenue for Q1 2024 was $695.4M, a -5.00% decrease from the previous quarter (Q4 2023), and a -2.96% decrease year-over-year (Q1 2023).

What is West Pharmaceutical Services’s revenue growth rate?

West Pharmaceutical Services's revenue growth rate for the last 3 years (2022-2024) was 0.22%, and for the last 5 years (2020-2024) was 34.76%.

What are West Pharmaceutical Services’s revenue streams?

West Pharmaceutical Services's revenue streams in c 24 are Contract Manufactured Products

What is West Pharmaceutical Services’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of West Pharmaceutical Services was Contract Manufactured Products. This segment made a revenue of $558.7M, representing 100.00% of the company's total revenue.